Stacy E.F. Melanson

2.3k total citations
99 papers, 1.6k citations indexed

About

Stacy E.F. Melanson is a scholar working on Public Health, Environmental and Occupational Health, Toxicology and Physiology. According to data from OpenAlex, Stacy E.F. Melanson has authored 99 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 28 papers in Toxicology and 23 papers in Physiology. Recurrent topics in Stacy E.F. Melanson's work include Forensic Toxicology and Drug Analysis (27 papers), Opioid Use Disorder Treatment (25 papers) and Clinical Laboratory Practices and Quality Control (22 papers). Stacy E.F. Melanson is often cited by papers focused on Forensic Toxicology and Drug Analysis (27 papers), Opioid Use Disorder Treatment (25 papers) and Clinical Laboratory Practices and Quality Control (22 papers). Stacy E.F. Melanson collaborates with scholars based in United States, Cyprus and United Kingdom. Stacy E.F. Melanson's co-authors include Petr Jarolı́m, Milenko J. Tanasijevic, David A. Morrow, James G. Flood, Athena K. Petrides, David W. Bates, R. Cooray, Steven A. Gustafson, Markus Zorn and S. Braun and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Stacy E.F. Melanson

92 papers receiving 1.6k citations

Peers

Stacy E.F. Melanson
Charles E. Leonard United States
Stacy E.F. Melanson
Citations per year, relative to Stacy E.F. Melanson Stacy E.F. Melanson (= 1×) peers Charles E. Leonard

Countries citing papers authored by Stacy E.F. Melanson

Since Specialization
Citations

This map shows the geographic impact of Stacy E.F. Melanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy E.F. Melanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy E.F. Melanson more than expected).

Fields of papers citing papers by Stacy E.F. Melanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacy E.F. Melanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy E.F. Melanson. The network helps show where Stacy E.F. Melanson may publish in the future.

Co-authorship network of co-authors of Stacy E.F. Melanson

This figure shows the co-authorship network connecting the top 25 collaborators of Stacy E.F. Melanson. A scholar is included among the top collaborators of Stacy E.F. Melanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacy E.F. Melanson. Stacy E.F. Melanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Phillip, Christiane Wolf, Varghese Thomas, et al.. (2025). Urine methamphetamine-to-amphetamine ratio by LC-MS/MS to differentiate methamphetamine use from pharmaceutical impurity in patients prescribed amphetamine. PubMed. 37. 49–55. 1 indexed citations
3.
Kumánovics, Attila, Stacy E.F. Melanson, Tanzy Love, et al.. (2024). Performance of Three Anti-SARS-CoV-2 Anti-S and One Anti-N Immunoassays for the Monitoring of Immune Status and Vaccine Response. Viruses. 16(2). 292–292. 1 indexed citations
4.
John, Andrew St, Christopher P. Price, Rogier Hopstaken, et al.. (2024). Challenges Associated with the Effective Implementation of New Laboratory Tests—The International Experience. Clinical Chemistry. 70(5). 693–699. 1 indexed citations
5.
Tolan, Nicole V., Phillip Kang, Peter R. Chai, et al.. (2024). Impact of COVID-19 on Drug Positivity Rates in the Emergency Departments in Boston and Surrounding Areas. The Journal of Applied Laboratory Medicine. 9(6). 1064–1070.
6.
Snozek, Christine L.H., Janetta Bryksin, Benjamin Gerson, et al.. (2024). Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals. American Journal of Clinical Pathology. 163(1). 69–79. 1 indexed citations
7.
Zhao, Zhen, Attila Kumánovics, Tanzy Love, et al.. (2023). T Cell Responses Correlate with Self-Reported Disease Severity and Neutralizing Antibody Responses Predict Protection against SARS-CoV-2 Breakthrough Infection. Viruses. 15(3). 709–709. 5 indexed citations
8.
Melanson, Stacy E.F., Karen Schulz, Zhen Zhao, et al.. (2023). Large-Scale Scientific Study Led by a Professional Organization during the COVID-19 Pandemic: Operations, Best Practices, and Lessons Learned. The Journal of Applied Laboratory Medicine. 9(2). 371–385. 1 indexed citations
9.
Genzen, Jonathan R., et al.. (2023). Robust Response of the Clinical Laboratory to the COVID-19 Pandemic despite Significant Challenges. The Journal of Applied Laboratory Medicine. 8(6). 1160–1172.
10.
Tolan, Nicole V., et al.. (2023). Estimated GFR With Cystatin C and Creatinine in Clinical Practice: A Retrospective Cohort Study. Kidney Medicine. 5(3). 100600–100600. 15 indexed citations
11.
Minkovsky, Alissa, Mark N. Lee, Mitra Dowlatshahi, et al.. (2016). High-Dose Biotin Treatment for Secondary Progressive Multiple Sclerosis May Interfere with Thyroid Assays. AACE Clinical Case Reports. 2(4). e370–e373. 39 indexed citations
12.
Yiadom, Maame Yaa A. B., Petr Jarolı́m, Cathy A. Jenkins, et al.. (2015). Diagnostic Implications of an Elevated Troponin in the Emergency Department. Disease Markers. 2015. 1–6. 13 indexed citations
13.
Melanson, Stacy E.F., et al.. (2014). Using Lean principles to optimise inpatient phlebotomy services. Journal of Clinical Pathology. 67(8). 724–730. 8 indexed citations
14.
Kosowsky, Joshua M., et al.. (2014). Clinical and financial impact of removing creatine kinase-MB from the routine testing menu in the emergency setting. The American Journal of Emergency Medicine. 33(1). 72–75. 19 indexed citations
15.
Melanson, Stacy E.F., et al.. (2013). Significant cost savings achieved by in-sourcing urine drug testing for monitoring medication compliance in pain management. Clinica Chimica Acta. 422. 10–14. 9 indexed citations
16.
Melanson, Stacy E.F., et al.. (2012). What Proportion of Vancomycin Trough Levels Are Drawn Too Early?. American Journal of Clinical Pathology. 137(3). 472–478. 49 indexed citations
17.
Melanson, Stacy E.F., Michael Conrad, Nima Mosammaparast, & Petr Jarolı́m. (2008). Implementation of a highly sensitive cardiac troponin I assay: Test volumes, positivity rates and interpretation of results. Clinica Chimica Acta. 395(1-2). 57–61. 31 indexed citations
18.
Melanson, Stacy E.F., David A. Morrow, & Petr Jarolı́m. (2007). Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved Sensitivity. American Journal of Clinical Pathology. 128(2). 282–286. 160 indexed citations
19.
Melanson, Stacy E.F., et al.. (2006). Does blood donor history accurately reflect the use of prescription medications? A comparison of donor history and serum toxicologic analysis. Transfusion. 46(8). 1402–1407. 15 indexed citations
20.
Melanson, Stacy E.F. & Elizabeth Lee Lewandrowski. (2005). Laboratory Testing for B-Type Natriuretic Peptides (BNP and NT-proBNP). PubMed. 124(suppl_1). S122–S128. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026